LifeMD Inc expected to post a loss of 14 cents a share - Earnings Preview

By Reuters News
  • LifeMD Inc LFMD.O is expected to show a fall in quarterly revenue when it reports results on November 12 for the period ending September 30 2026

  • The New York City-based company is expected to report a 18.8% decrease in revenue to $48.885 million from $60.17 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.The company's guidance on August 5 2026, for the period ended September 30, was for revenue between $48.00 million and $51.00 million.

  • ​LSEG's mean analyst estimate for LifeMD Inc is for a loss of 14 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for LifeMD Inc is $7.50, about 258% above its last closing price of $2.10

The company's guidance on August 5 2026 for the period ended September 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 48 million and 2 million (USD).

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Jun. 30 2026

-0.16

-0.15

-0.16

Missed

-9.8

Mar. 31 2026

-0.23

-0.22

-0.20

Beat

9.9

Dec. 31 2025

-0.06

-0.03

-0.04

Missed

-20​

Sep. 30 2025

-0.05

-0.05

-0.07

Missed

-50

​​Jun. 30 2025

0.01

-0.01

-0.06

Missed

-650

Mar. 31 2025

-0.06

-0.05

0.01

Beat

118.9​

Dec. 31 2024

-0.07

-0.05

-0.02

Beat

61.1

Sep. 30 2024

-0.12

-0.12

-0.14

Missed

-18

This summary was machine generated November 10 at 21:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk